Paediatric Hematologic Research Group
1 – 50 of 122
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Dilemmas on emicizumab in children with haemophilia A : A survey of strategies from PedNet centres
(
- Contribution to journal › Article
- 2017
-
Mark
Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.
(
- Contribution to journal › Article
-
Mark
Endovascular treatment of vein of Galen aneurysmal malformation using rapid ventricular pacing : A case report
(
- Contribution to journal › Article
-
Mark
Cerebellar mutism syndrome in children with brain tumours of the posterior fossa
(
- Contribution to journal › Article
-
Mark
Ataxia-pancytopenia syndrome with SAMD9L mutations
(
- Contribution to journal › Article
- 2016
-
Mark
Origin of mutation in sporadic cases of severe haemophilia A in Sweden.
(
- Contribution to journal › Article
-
Mark
Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
(
- Contribution to journal › Article
-
Mark
BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.
(
- Contribution to journal › Article
-
Mark
Breath-holding spells occur disproportionately more often in children with transient erythroblastopenia
(
- Contribution to journal › Article
- 2015
-
Mark
Haemophilia in Sweden – Studies on mutations and clinical implications
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
The current status of prophylactic replacement therapy in children and adults with haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology
(
- Contribution to journal › Article
-
Mark
Switching treatments in haemophilia: is there a risk of inhibitor development?
(
- Contribution to journal › Scientific review
-
Mark
Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.
2015) In Haemophilia(
- Contribution to journal › Article
- 2014
-
Mark
Prenatal diagnosis of haemophilia in Sweden now more commonly used for psychological preparation than termination of pregnancy.
(
- Contribution to journal › Article
-
Mark
Factor VIII therapy for hemophilia A: current and future issues
(
- Contribution to journal › Scientific review
-
Mark
Perinatal aspects of haemophilia
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
(
- Contribution to journal › Article
-
Mark
Origin of Swedish hemophilia B mutations
(
- Contribution to journal › Article
-
Mark
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
(
- Contribution to journal › Article
-
Mark
Plastic surgical treatment of purpura fulminans: Long-term follow-up of two patients.
(
- Contribution to journal › Article
- 2012
-
Mark
Lupus anticoagulants in two children-bleeding due to nonphospholipid-dependent antiprothrombin antibodies.
(
- Contribution to journal › Article
-
Mark
Haemophilia Care in Europe: the ESCHQoL study
(
- Contribution to journal › Article
-
Mark
Origin of Swedish hemophilia A mutations
(
- Contribution to journal › Article
-
Mark
Investigation of disease-associated factors in haemophilia A patients without detectable mutations.
(
- Contribution to journal › Article
-
Mark
How to manage invasive procedures in children with haemophilia.
(
- Contribution to journal › Article
-
Mark
Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.
(
- Contribution to journal › Article
-
Mark
New treatments in hemophilia: insights for the clinician.
(
- Contribution to journal › Article
- 2011
-
Mark
Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?
(
- Contribution to journal › Article
-
Mark
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
(
- Contribution to journal › Article
-
Mark
The need for speed in the management of haemophilia patients with inhibitors
(
- Contribution to journal › Article
-
Mark
Joint protection in haemophilia
(
- Contribution to journal › Article
-
Mark
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
(
- Contribution to journal › Article
-
Mark
Delivery of a severe haemophilia foetus - vaginal delivery
(
- Contribution to journal › Published meeting abstract
-
Mark
Ovanliga ärftliga former av blödarsjuka. Blödningssymtom, familjehistoria och laboratorieanalyser ger diagnosen.
(
- Contribution to journal › Article
-
Mark
Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden
2011) XXIII Congress of the International Society on Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 9. p.462-462(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Management of bleedings in carriers
(
- Contribution to journal › Published meeting abstract
-
Mark
European Initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study
(
- Contribution to journal › Published meeting abstract
-
Mark
Why is the frequency of inhibitors increasing among Swedish children with severe hemophilia A?
(
- Contribution to journal › Published meeting abstract
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
(
- Contribution to journal › Scientific review
-
Mark
Hemophilia A patients without detectable mutations - investigation of disease-associated factors
(
- Contribution to journal › Published meeting abstract
-
Mark
Quality of life in parents of children with haemophilia - results of the ESCHQoL study
(
- Contribution to journal › Published meeting abstract
-
Mark
European initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study
(
- Contribution to journal › Published meeting abstract
-
Mark
The Fourth Annual Meeting of the International Network for Pediatric Hemophilia: Current Challenges and Recommendations in the Clinical Care of Children with Hemophilia.
(
- Contribution to journal › Article
-
Mark
Anti-prothrombin antibodies are associated with thrombosis in children.
(
- Contribution to journal › Article
-
Mark
The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery.
(
- Contribution to journal › Article
-
Mark
Venös tromboembolism hos barn
2010) p.161-174(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2009
-
Mark
Prophylactic therapy in haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
(
- Contribution to journal › Article